A pilot placebo-controlled study of trazodone and buspirone in alzheimer's disease
- 1 January 1994
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 9 (1) , 55-59
- https://doi.org/10.1002/gps.930090112
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.Proceedings of the National Academy of Sciences, 1989
- Hyperresponsivity to the Serotonin Agonist m-Chlorophenylpiperazine in Alzheimer's DiseaseArchives of General Psychiatry, 1989
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- SEROTONINERGIC TREATMENT OF SCREAMING AND BANGING IN DEMENTIAThe Lancet, 1986
- Binding of the Novel Serotonin Agonist 8‐Hydroxy‐2‐(Di‐n‐Propylamino) Tetralin in Normal and Alzheimer BrainJournal of Neurochemistry, 1986
- The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementiaNeurobiology of Aging, 1986
- Serotonin Receptor Changes in Dementia of the Alzheimer TypeJournal of Neurochemistry, 1984
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Trazodone, a central serotonin antagonist and agonistJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Selective reminding for analysis of memory and learningJournal of Verbal Learning and Verbal Behavior, 1973